ACH
CLBT icon

ArrowMark Colorado Holdings’s Cellebrite CLBT Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.86M Sell
538,040
-959,293
-64% -$12.7M 0.33% 124
2026
Q1 		$20.6M Buy
1,497,333
+414,373
+38% +$6.25M 0.55% 56
2025
Q4 		$19.5M Sell
1,082,960
-244,922
-18% -$4.4M 0.43% 68
2025
Q3 		$24.6M Buy
1,327,882
+63,599
+5% +$999K 0.46% 68
2025
Q2 		$20.2M Buy
+1,264,283
New +$22.5M 0.36% 79

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

ArrowMark Colorado Holdings's CLBT Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its Cellebrite (CLBT) stake by 64% in Q2 2026, selling an estimated $12.7M and leaving 538,040 shares worth $7.86M. The position accounts for 0.33% of the portfolio, ranked #124.

ArrowMark Colorado Holdings first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. The position peaked at $24.6M in Q3 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • ArrowMark Colorado Holdings held 538,040 shares of Cellebrite worth $7.86M as of Q2 2026.
  • ArrowMark Colorado Holdings sold 959,293 Cellebrite shares in Q2 2026, an estimated $12.7M.
  • Cellebrite made up 0.33% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #124 holding.
  • ArrowMark Colorado Holdings first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • ArrowMark Colorado Holdings's Cellebrite position peaked at $24.6M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.